Interpace Biosciences Files 2024 Annual Report Amendment
Ticker: IDXG · Form: 10-K/A · Filed: Apr 28, 2025 · CIK: 1054102
| Field | Detail |
|---|---|
| Company | Interpace Biosciences, Inc. (IDXG) |
| Form Type | 10-K/A |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, filing
TL;DR
INTERPACE BIOSCIENCES, INC. FILED ITS AMENDED 2024 ANNUAL REPORT ON 4/28/2025. CHECK FOR UPDATES.
AI Summary
Interpace Biosciences, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The filing, submitted on April 28, 2025, provides updated information for the company, which is involved in the Surgical & Medical Instruments & Apparatus industry. The company's principal executive offices are located in Parsippany, New Jersey.
Why It Matters
This amendment to the annual report provides updated financial and operational information for Interpace Biosciences, Inc., which is crucial for investors and stakeholders to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This filing is an amendment to an annual report and does not introduce new material risks or significant changes in the company's risk profile.
Key Numbers
- 2024 — Fiscal Year End (The annual report covers the fiscal year ending December 31, 2024.)
- 20250428 — Filing Date (The amendment was filed on April 28, 2025.)
Key Players & Entities
- INTERPACE BIOSCIENCES, INC. (company) — Registrant
- 000-24249 (company) — SEC File Number
- 20241231 (date) — Fiscal Year End
- 20250428 (date) — Filing Date
- Parsippany, NJ (location) — Business Address
FAQ
What is the primary purpose of this 10-K/A filing?
This filing is an amendment to the annual report (10-K) for the fiscal year ended December 31, 2024, for Interpace Biosciences, Inc.
When was this amendment filed with the SEC?
The amendment was filed on April 28, 2025.
What is the SEC file number for Interpace Biosciences, Inc.?
The SEC file number for Interpace Biosciences, Inc. is 000-24249.
Where are Interpace Biosciences, Inc.'s principal executive offices located?
The company's principal executive offices are located at Waterview Plaza, Suite 310, 2001 Route 46, Parsippany, NJ 07054.
What industry does Interpace Biosciences, Inc. operate in?
Interpace Biosciences, Inc. operates in the Surgical & Medical Instruments & Apparatus industry, with SIC code 3841.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 28, 2025 regarding INTERPACE BIOSCIENCES, INC. (IDXG).